impetigo%20-and-%20ecthyma%20(pediatric)
IMPETIGO & ECTHYMA (PEDIATRIC)
Impetigo is a very contagious, superficial, bacterial skin infection that easily spreads among people in close contact.
Most cases resolve spontaneously without scarring in approximately 14 days without treatment.
Ecthyma is deeply ulcerated form of impetigo that extends to the dermis. The ulcers are "punched-out" with yellow crust and elevated violaceous margins.
It may be an infection de novo or a superinfection.

Patient Education

Parental Education

  • To prevent contagious spread, patient should avoid contact w/ noninfected persons & avoid sharing of towels, sheets, etc
  • Child must not return to daycare or school until there is no further crusting or until 48 hours after initiation of antibiotic treatment
  • Practice simple cleanliness (eg washing hands after contact w/ infected persons, daily baths)
  • Daily cleaning of the lesions w/ antiseptic soap & water may prevent recurrence at distant sites
  • Keep the child’s fingernails short & to avoid scratching the lesions
  • Improve nutritional status & treat underlying conditions
  • Return child for follow-up if condition did not improve 7 days after starting therapy or sooner if condition worsened
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 5 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
3 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.